NCT04812002 2022-06-03Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined ChemotherapyWomen's Hospital School Of Medicine Zhejiang UniversityPhase 2 Unknown20 enrolled